Content Carnivores LLC to Represent Global Life Sciences Clients at BIO International Convention 2025

Innovative marketing communications firm to showcase innovative companies from North America and Europe at premier biotechnology conference

Key Takeaways

  • Innovation Velocity Demands Global Collaboration. Complex breakthrough therapies like novel cancer treatments require international partnerships for expertise, funding, and regulatory navigation that no single country can provide alone.
  • Regional Hubs Are Becoming Global Gateways for Market Access. Strategic ecosystems like Utah offer international companies competitive advantages in talent, manufacturing, and regulatory pathways for efficiently entering complex global markets.
  • The Convergence of AI, Precision Medicine, and Manufacturing Innovation. Biotech's evolution toward integrated AI-driven solutions and precision therapeutics makes international collaboration essential for competitive success and urgent patient impact.

CHICAGO, IL and PARK CITY, UT – June 12, 2025– Content Carnivores LLC, a specialized marketing communications firm serving the global life sciences industry with offices in Chicago, Illinois and Park City, Utah, announces its participation in the BIO International Convention taking place June 16-19, 2025, at the Boston Convention and Exhibition Center.

The company is excited to support the transformative developments in the biotech industry by facilitating connections between international partners and clients. Content Carnivores will focus on three key areas: helping companies differentiate their science, identifying emerging industry trends in manufacturing, marketing, and funding, and positioning clients at the forefront of modern medicine's future.

Content Carnivores will represent several innovative clients from across North America and Europe at the convention, each addressing critical unmet medical needs:

Content Carnivores is proud to represent Pacylex Pharmaceuticals, a clinical-stage company based in Edmonton, Alberta, Canada, in partnership with the University of Alberta. The company is developing zelenirstat, a first-in-class oral cancer therapy targeting N-myristoyltransferase (NMT) inhibition. This University of Alberta spinoff has achieved significant milestones:

  • Recent Progress: Zelenirstat completed Phase 1 trials demonstrating acceptable safety and early signs of efficacy across multiple cancer types
  • AML Focus: The drug has received both Orphan Drug Designation and Fast Track Designation from the FDA for acute myeloid leukemia (AML)
  • Expanding Trials: A new Phase 1/2 trial in relapsed/refractory AML patients launched in March 2025, with the first patient recently dosed
  • MD Anderson Partnership: The U.S. Department of Defense is supporting clinical investigations at MD Anderson Cancer Center
  • Broad Application: Currently in Phase 2a studies for relapsed/refractory B-cell non-Hodgkin lymphoma and refractory metastatic colorectal cancer

The firm’s Life Sciences VP, Chelli Miller, represents Akrivia Health, originating from Oxford University and the NHS. Akrivia’s cutting-edge technology aims to enhance the physician's patient story view, advancing the quality of care for patients with depression, schizophrenia, and other clinical conditions by leveraging advanced artificial intelligence capabilities to improve psychiatric treatment outcomes. She will be meeting with current and future US partners and investors on their behalf.


In addition to its international clients, Content Carnivores will showcase the remarkable opportunities emerging in Utah's life sciences sector and highlight Utah's strategic advantages for global life sciences companies seeking North American operations. Factors to consider include:

  • Rapid Growth: Utah ranks among the fastest-growing life sciences industries in the nation with 5.1% average annual job growth over the past decade
  • Economic Impact: The industry generates over $500 million in net positive fiscal impacts to the state
  • High-Quality Workforce: Utah maintains the third-highest density of life sciences jobs nationally, with wages approximately 50% higher than the state average
  • Infrastructure Development: New laboratory and manufacturing facilities specifically designed for life sciences companies

Content Carnivores is collaborating with BioUtah, Utah's premier life sciences trade association, and will be at the official State of Utah Pavilion Exhibit 783 during the convention. The Utah Pavillion brings together:

  • Representatives from the Governor's office
  • Key trade association leaders
  • Leading economic development partners
  • University system stakeholders
  • Cutting-edge Utah innovators
  • Life Science infrastructure experts

Throughout the four-day convention, Content Carnivores will:

  • Participate in key conference activities and networking events
  • Facilitate meetings between international clients and potential partners, investors, and key opinion leaders
  • Showcase Utah's unique advantages as a North American life sciences hub for global companies
  • Demonstrate the innovative approaches these international companies are taking to address critical healthcare challenges worldwide

"We're thrilled to represent this exceptional group of companies and showcase the global collaboration happening in life sciences," said Chelli Miller, VP of Client Success and Partner at Content Carnivores LLC. "The BIO International Convention provides an ideal platform to present our clients' groundbreaking innovations from Canada and the UK, while also demonstrating Utah's emergence as a premier North American destination for international life sciences companies."



ABOUT CONTENT CARNIVORES, LLC
Content Carnivores is dedicated to delivering the highest standards of ideas and writing so that greatness finds its widest audience to deliver on business objectives. Headquartered in Chicago with an office in Park City, Utah, they leverage proprietary technology that dramatically speeds up the discovery, creation, and publication of high-quality content to help brands and businesses amplify awareness and establish thought leadership to their target audiences.

The company founders have run innovative content marketing and advertising programs for global marketing pioneers. Current clients include leaders in healthcare, marketing, medical devices, financial services, and technology.

Key Takeaways

  • Innovation Velocity Demands Global Collaboration. Complex breakthrough therapies like novel cancer treatments require international partnerships for expertise, funding, and regulatory navigation that no single country can provide alone.
  • Regional Hubs Are Becoming Global Gateways for Market Access. Strategic ecosystems like Utah offer international companies competitive advantages in talent, manufacturing, and regulatory pathways for efficiently entering complex global markets.
  • The Convergence of AI, Precision Medicine, and Manufacturing Innovation. Biotech's evolution toward integrated AI-driven solutions and precision therapeutics makes international collaboration essential for competitive success and urgent patient impact.

Media Gallery

Video Gallery

Government, Acadamia, Trade Groups, Investors and More
Download

Quotes

“
We're thrilled to represent this exceptional group of international companies and highlight the global collaboration happening in life sciences. Th...
Chelli Miller — Partner and Iron Chef

Related Bios

Jeffrey Walker
Founder and CEO
Helping 1,000+ Companies strategize, create and share their stories with the audiences they need to reach in the most relevant channels in which to reach them. Financial, Investment and Biotech expert. Strategize. Energize. Monetize. Eat.

Ongoing successes for long-standing clients in VC, Investment Research, Investor Relations, Investor Events. Biotech, Tech and many niche category experts.
View Full Bio>>
Chelli Miller
Partner and Iron Chef
Biotech Company, Investor and Events Expert | VP at Content Carnivores

Content Carnivores, LLC, is a technology and services company specializing in all things related to the financial world. This includes working not just with the companies, but with Analysts, IR firms, PR firms, Investors and others in the biotech ecosystem.

I began in healthcare, managing the presenting company-side of a small-cap/private investor conference that ran simultaneously to the JP Morgan Healthcare Conference. This allowed me to build a reputation that provides me with an unprecedented reach into new and evolving Life Science tech, innovative marketing and communications platforms, related investor world, and strategic relationships.

Skills:

Strategy: concept, design and execution
Social Media Marketing
Marketing/IR/Sales strategies
Tactical programs, strategy, client services, product, user experience
Media/PR
Event strategies
Content Marketing
Events

Categories:

Healthcare
Biotechnology
Alternative Finance
Financial Services
Small Cap and OTC Markets
Investor Relations
Education
Nonprofit
Music industry

Specialties: Strategic Media and Content Marketing Program, Customized Client Services: growth strategies, product commercialization and launch strategies, investor strategies including IPO readiness, strategic partnerships, social media, networking, events, telling people what to do, having too much fun!
View Full Bio>>

Contacts

Chelli Miller
chelli@contentcarnivores.com
219-921-6823